245 related articles for article (PubMed ID: 34942552)
1. Global, regional and national burden of primary liver cancer by subtype.
Rumgay H; Ferlay J; de Martel C; Georges D; Ibrahim AS; Zheng R; Wei W; Lemmens VEPP; Soerjomataram I
Eur J Cancer; 2022 Jan; 161():108-118. PubMed ID: 34942552
[TBL] [Abstract][Full Text] [Related]
2. Global burden of oesophageal and gastric cancer by histology and subsite in 2018.
Arnold M; Ferlay J; van Berge Henegouwen MI; Soerjomataram I
Gut; 2020 Sep; 69(9):1564-1571. PubMed ID: 32606208
[TBL] [Abstract][Full Text] [Related]
3. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation.
Burton A; Tataru D; Driver RJ; Bird TG; Huws D; Wallace D; Cross TJS; Rowe IA; Alexander G; Marshall A;
JHEP Rep; 2021 Apr; 3(2):100232. PubMed ID: 33748727
[TBL] [Abstract][Full Text] [Related]
4. Global burden of primary liver cancer in 2020 and predictions to 2040.
Rumgay H; Arnold M; Ferlay J; Lesi O; Cabasag CJ; Vignat J; Laversanne M; McGlynn KA; Soerjomataram I
J Hepatol; 2022 Dec; 77(6):1598-1606. PubMed ID: 36208844
[TBL] [Abstract][Full Text] [Related]
5. Global variations in lung cancer incidence by histological subtype in 2020: a population-based study.
Zhang Y; Vaccarella S; Morgan E; Li M; Etxeberria J; Chokunonga E; Manraj SS; Kamate B; Omonisi A; Bray F
Lancet Oncol; 2023 Nov; 24(11):1206-1218. PubMed ID: 37837979
[TBL] [Abstract][Full Text] [Related]
6. Impact of socio-economic environment on incidence of primary liver cancer in France between 2006 and 2016.
Comoz B; Ollivier-Hourmand I; Bouvier AM; Nousbaum JB; Nguyen TTN; Launoy G; Bouvier V; Bryere J
Liver Int; 2024 Feb; 44(2):446-453. PubMed ID: 38010978
[TBL] [Abstract][Full Text] [Related]
7. Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method.
Yeesoonsang S; Bilheem S; McNeil E; Iamsirithaworn S; Jiraphongsa C; Sriplung H
Cancer Res Treat; 2017 Jan; 49(1):54-60. PubMed ID: 27188200
[TBL] [Abstract][Full Text] [Related]
8. Global patterns of cardia and non-cardia gastric cancer incidence in 2012.
Colquhoun A; Arnold M; Ferlay J; Goodman KJ; Forman D; Soerjomataram I
Gut; 2015 Dec; 64(12):1881-8. PubMed ID: 25748648
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries.
An L; Zheng R; Zhang S; Chen R; Wang S; Sun K; Lu L; Zhang X; Zhao H; Zeng H; Wei W; He J
Hepatobiliary Surg Nutr; 2023 Feb; 12(1):45-55. PubMed ID: 36860251
[TBL] [Abstract][Full Text] [Related]
10. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Cirrhosis Collaborators
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly.
Chon YE; Park SY; Hong HP; Son D; Lee J; Yoon E; Kim SS; Ahn SB; Jeong SW; Jun DW
Clin Mol Hepatol; 2023 Jan; 29(1):120-134. PubMed ID: 35957547
[TBL] [Abstract][Full Text] [Related]
12. International trends in hepatocellular carcinoma incidence, 1978-2012.
Petrick JL; Florio AA; Znaor A; Ruggieri D; Laversanne M; Alvarez CS; Ferlay J; Valery PC; Bray F; McGlynn KA
Int J Cancer; 2020 Jul; 147(2):317-330. PubMed ID: 31597196
[TBL] [Abstract][Full Text] [Related]
13. Revealing the role of necroptosis microenvironment: FCGBP + tumor-associated macrophages drive primary liver cancer differentiation towards cHCC-CCA or iCCA.
Wang C; Chen C; Hu W; Tao L; Chen J
Apoptosis; 2024 Apr; 29(3-4):460-481. PubMed ID: 38017206
[TBL] [Abstract][Full Text] [Related]
14. Comparison of primary liver cancer mortality estimates from World Health Organization, global burden disease and global cancer observatory.
Li C; He WQ
Liver Int; 2022 Oct; 42(10):2299-2316. PubMed ID: 35779247
[TBL] [Abstract][Full Text] [Related]
15. Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
Sayiner M; Golabi P; Younossi ZM
Dig Dis Sci; 2019 Apr; 64(4):910-917. PubMed ID: 30835028
[TBL] [Abstract][Full Text] [Related]
16. International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.
Petrick JL; Braunlin M; Laversanne M; Valery PC; Bray F; McGlynn KA
Int J Cancer; 2016 Oct; 139(7):1534-45. PubMed ID: 27244487
[TBL] [Abstract][Full Text] [Related]
17. The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels.
Yang J; Pan G; Guan L; Liu Z; Wu Y; Liu Z; Lu W; Li S; Xu H; Ouyang G
Cancer Med; 2022 Mar; 11(5):1357-1370. PubMed ID: 34989144
[TBL] [Abstract][Full Text] [Related]
18. MYC determines lineage commitment in KRAS-driven primary liver cancer development.
D'Artista L; Moschopoulou AA; Barozzi I; Craig AJ; Seehawer M; Herrmann L; Minnich M; Kang TW; Rist E; Henning M; Klotz S; Heinzmann F; Harbig J; Sipos B; Longerich T; Eilers M; Dauch D; Zuber J; Wang XW; Zender L
J Hepatol; 2023 Jul; 79(1):141-149. PubMed ID: 36906109
[TBL] [Abstract][Full Text] [Related]
19. International incidence of childhood cancer, 2001-10: a population-based registry study.
Steliarova-Foucher E; Colombet M; Ries LAG; Moreno F; Dolya A; Bray F; Hesseling P; Shin HY; Stiller CA;
Lancet Oncol; 2017 Jun; 18(6):719-731. PubMed ID: 28410997
[TBL] [Abstract][Full Text] [Related]
20. Trends in the prevalence and disability-adjusted life years of eating disorders from 1990 to 2017: results from the Global Burden of Disease Study 2017.
Wu J; Liu J; Li S; Ma H; Wang Y
Epidemiol Psychiatr Sci; 2020 Dec; 29():e191. PubMed ID: 33283690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
